| | | | | |
RNAC Cartesian Therapeutics, Inc. Common Stock | $10,0740 | +0,34% | $317,37M | $45,52K | |
FUND Sprott Focus Trust, Inc. | $10,8600 | -0,18% | $317,19M | $2,81K | |
FATE Fate Therapeutics, Inc. | $2,3550 | +1,07% | $317,04M | $635,59K | |
NMRA Neumora Therapeutics, Inc. Common Stock | $1,6150 | -0,92% | $316,83M | $294,11K | |
GALT Galectin Therapeutics Inc. | $3,8560 | +4,78% | $316,66M | $83,51K | |
NREF NexPoint Real Estate Finance, Inc. | $17,6450 | +3,31% | $316,64M | $20,92K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | $10,8550 | +0,23% | $316,34M | $362,00 | |
PSBD Palmer Square Capital BDC Inc. | $10,3210 | +0,50% | $316,32M | $24,04K | |
| $3,2040 | -1,11% | $316,09M | $145,96K | |
| $6,4020 | -1,05% | $315,88M | $42,24K | |
SMTI Sanara MedTech Inc. Common Stock | $34,3040 | -0,42% | $315,59M | $151,94K | |
MLP Maui Land & Pineapple Co. | $15,7400 | +0,51% | $315,56M | $4,61K | |
AFB Alliance National Municipal Income Fund, Inc. | $10,9300 | +0,18% | $315,33M | $6,91K | |
| $41,3050 | +0,74% | $315,30M | $5,31K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | $10,5350 | +0,00% | $315,30M | $68,17K | |
